Dexrazoxane Kit
Product Images NDC 55150-437

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dexrazoxane (NDC 55150-437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexrazoxane-fig1 (Dexrazoxane Fig1)

A bar chart showing the cumulative number of patients on treatment comparing FAC versus FAC/DEXRAZOXANE patients receiving at least seven courses of treatment. The x-axis represents the cumulative dose of Doxorubicin in mg/m², ranging from 350 to 1000+. The y-axis shows the number of patients, from 0 to 120. White bars represent the FAC/DEXRAZOXANE group, and black bars represent the FAC group, illustrating patient counts across dose ranges.*

FDA Label Image

Dexrazoxane-fig2 (Dexrazoxane Fig2)

Label for Dexrazoxane for Injection, 250 mg per vial, sterile pyrogen-free lyophilizate in a single-dose vial. Indicated for intravenous use only. The label includes storage instructions, manufacturer information (AuroMedics Pharma LLC), and directions regarding solution preparation and stability. NDC 55150-432-01 is displayed prominently.*

FDA Label Image

Dexrazoxane-fig3 (Dexrazoxane Fig3)

Label for Sodium Lactate Injection, USP 0.167 Molar (M/6), 25 mL single-dose vial. It is sterile, for drug diluent use only, and not for treatment of lactic acidosis. Contains 18.7 mg sodium lactate per mL. Manufactured in India for AuroMedics Pharma LLC, E. Windsor, NJ, with a barcode and batch/expiry placeholders. Labeler is Eugia US LLC.*

FDA Label Image

Dexrazoxane-fig4 (Dexrazoxane Fig4)

Label packaging for Dexrazoxane for Injection 250 mg per vial and Sodium Lactate Injection, USP 0.167M (M/6) kit. The product is for intravenous use only and supplied as sterile, pyrogen-free lyophilizate in single-dose vials. Distributed by AuroMedics Pharma LLC and made in India, the label includes storage instructions and barcode.*

FDA Label Image

Dexrazoxane-fig5 (Dexrazoxane Fig5)

Label of Dexrazoxane for Injection 500 mg per vial, sterile, pyrogen-free lyophilizate, single-dose vial. Intended for intravenous use only. Manufactured in India for AuroMedics Pharma LLC. Contains instructions for reconstitution and storage, along with dosage guidance and barcode on the right side.*

FDA Label Image

Dexrazoxane-fig6 (Dexrazoxane Fig6)

Label of Sodium Lactate Injection, USP 0.167 Molar in a 50 mL single-dose vial, sterile and for drug diluent use only. The label includes storage instructions, dosage guidance, and manufacturer information for AuroMedics Pharma LLC, with the product made in India. Barcode and batch/expiry fields are present on the right side.*

FDA Label Image

Dexrazoxane-fig7 (Dexrazoxane Fig7)

Packaging label for Dexrazoxane for Injection 500 mg per vial and 0.167M (M/6) Sodium Lactate Injection, USP. The kit includes one 500 mg single-dose vial of Dexrazoxane and one 50 mL single-dose vial of sodium lactate injection as diluent. The product is sterile, pyrogen-free lyophilizate intended for intravenous use only. Labeler is Eugia US LLC.*

FDA Label Image

Dexrazoxane-str (Dexrazoxane Str)

Chemical structure of dexrazoxane showing its molecular formula C11H16N4O4 and molecular weight of 268.28.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.